These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12359657)

  • 41. Thiazolidinediones and congestive heart failure in veterans with type 2 diabetes.
    Toprani A; Fonseca V
    Diabetes Obes Metab; 2011 Mar; 13(3):276-80. PubMed ID: 21205120
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lung spirometry parameters and diffusion capacity are decreased in patients with Type 2 diabetes.
    Klein OL; Kalhan R; Williams MV; Tipping M; Lee J; Peng J; Smith LJ
    Diabet Med; 2012 Feb; 29(2):212-9. PubMed ID: 21790775
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Abnormalities of pulmonary function in patients with non-insulin-dependent diabetes mellitus.
    Mori H; Okubo M; Okamura M; Yamane K; Kado S; Egusa G; Hiramoto T; Hara H; Yamakido M
    Intern Med; 1992 Feb; 31(2):189-93. PubMed ID: 1600265
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute saline infusion reduces alveolar-capillary membrane conductance and increases airflow obstruction in patients with left ventricular dysfunction.
    Puri S; Dutka DP; Baker BL; Hughes JM; Cleland JG
    Circulation; 1999 Mar; 99(9):1190-6. PubMed ID: 10069787
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The alveolar-capillary membrane diffusing capacity and the pulmonary capillary blood volume in heart transplant candidates.
    Al-Rawas OA; Carter R; Stevenson RD; Naik SK; Wheatley DJ
    Heart; 2000 Feb; 83(2):156-60. PubMed ID: 10648487
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lack of improvement of lung diffusing capacity following fluid withdrawal by ultrafiltration in chronic heart failure.
    Agostoni PG; Guazzi M; Bussotti M; Grazi M; Palermo P; Marenzi G
    J Am Coll Cardiol; 2000 Nov; 36(5):1600-4. PubMed ID: 11079664
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pulmonary function changes related to acute and chronic administration of inhaled insulin.
    Hegewald M; Crapo RO; Jensen RL
    Diabetes Technol Ther; 2007 Jun; 9 Suppl 1():S93-S101. PubMed ID: 17563309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Keeping the right track in the treatment of patients with type 2 diabetes.
    Avogaro A
    Eur J Heart Fail; 2018 Jan; 20(1):52-54. PubMed ID: 29251397
    [No Abstract]   [Full Text] [Related]  

  • 49. Reply to commentary on: confusion in reporting pulmonary diffusion capacity for nitric oxide and the alveolar-capillary membrane conductance for nitric oxide.
    Agostoni P; Magini A; Apostolo A
    Eur J Prev Cardiol; 2015 Mar; 22(3):314-6. PubMed ID: 24659025
    [No Abstract]   [Full Text] [Related]  

  • 50. Pulmonary function in non-insulin-dependent diabetes mellitus.
    Marvisi M; Bartolini L; del Borrello P; Brianti M; Marani G; Guariglia A; Cuomo A
    Respiration; 2001; 68(3):268-72. PubMed ID: 11416247
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Confusion in reporting pulmonary diffusing capacity for nitric oxide and the alveolar-capillary membrane conductance for nitric oxide.
    Zavorsky GS; Borland C
    Eur J Prev Cardiol; 2015 Mar; 22(3):312-3. PubMed ID: 24676716
    [No Abstract]   [Full Text] [Related]  

  • 52. Increased alveolar/capillary membrane resistance to gas transfer in patients with chronic heart failure.
    Puri S; Baker BL; Oakley CM; Hughes JM; Cleland JG
    Br Heart J; 1994 Aug; 72(2):140-4. PubMed ID: 7917686
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alveolar gas exchange in patients with type 2 diabetes mellitus.
    Guvener N; Tutuncu NB; Akcay S; Eyuboglu F; Gokcel A
    Endocr J; 2003 Dec; 50(6):663-7. PubMed ID: 14709835
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The diabetic lung: relevance of alveolar microangiopathy for the use of inhaled insulin.
    Hsia CC; Raskin P
    Am J Med; 2005 Mar; 118(3):205-11. PubMed ID: 15745714
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diffusing capacity for carbon monoxide in children with type 1 diabetes.
    Villa MP; Montesano M; Barreto M; Pagani J; Stegagno M; Multari G; Ronchetti R
    Diabetologia; 2004 Nov; 47(11):1931-5. PubMed ID: 15565372
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pulmonary capillary recruitment during exercise after detraining in a young man with small lungs.
    Donnelly PM; Bye PT
    Eur Respir J; 1995 May; 8(5):877. PubMed ID: 7656968
    [No Abstract]   [Full Text] [Related]  

  • 57. Reduction of alveolar-capillary diffusion after inhalation of endotoxin in normal subjects.
    Herbert A; Carvalheiro M; Rubenowitz E; Bake B; Rylander R
    Chest; 1992 Oct; 102(4):1095-8. PubMed ID: 1395750
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Type II diabetes mellitus, congestive heart failure, and zinc metabolism.
    Golik A; Cohen N; Ramot Y; Maor J; Moses R; Weissgarten J; Leonov Y; Modai D
    Biol Trace Elem Res; 1993; 39(2-3):171-5. PubMed ID: 7509174
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heart Failure: Epidemiology, Pathophysiology, and Management of Heart Failure in Diabetes Mellitus.
    Jorsal A; Wiggers H; McMurray JJV
    Endocrinol Metab Clin North Am; 2018 Mar; 47(1):117-135. PubMed ID: 29407047
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diabetes mellitus vs. Raynaud disease: different lung vascular bed disorders.
    Boulbou MS; Gourgoulianis KI; Krommydas GC; Klisiaris VK; Arseniou AA; Dafopoulos KC; Molyvdas PA
    Arch Med Res; 2002; 33(6):531-5. PubMed ID: 12505097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.